Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Plano contact lens warning

This article was originally published in The Gray Sheet

Executive Summary

FDA letters to Yahoo! and eBay are aimed at curtailing online sale of decorative cosmetic contact lenses without involvement of vision professionals, agency reports Oct. 10. FDA also highlights recent warning letter to BWild Inc., and states that "additional inspections are planned." The news release is part of ongoing efforts to educate consumers about the dangers of plano contacts (1"The Gray Sheet" Oct. 13, 2003, p. 21)...

You may also be interested in...

FDA News In Brief

OC strategic plan oversight: CDER Director Janet Woodcock, detailed to the Office of the Commissioner starting Oct. 20, will facilitate implementation of cross-cutting initiatives at agency centers, Oct. 7 FDA memo indicates. Although the detail is set for six months, it could evolve into a longer-term position. In the memo, the agency also announces plans to create a strategic plan council and regulatory policy council and to hold bimonthly "two on twos" between the commissioner/deputy commissioner and center directors/deputy center directors in lieu of executive council meetings...

EWG Study Suggests More Than One In 10 Talc-Based Cosmetics Contain Asbestos

The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.

US FDA Reaffirms Commitment To Resuming Domestic Inspections As Industry Frustration Grows

Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts